Posted by Michael Wonder on 06 Mar 2018
Government to cut price of Opdivo by over 20%
5 March 2018 - Japan’s health ministry said Monday that the government-set price of cancer drug Opdivo will be reduced by over 20% from the current level in fiscal 2018, which starts next month.
According to an official gazette from the ministry, the price of the drug for lung cancer and other illnesses will decline by 23.8%, to about ¥278,000 per 100 milligrams from the current ¥365,000.
Opdivo was registered as a skin cancer medication when it joined the list of drugs covered by the country’s public health insurance system in 2014. At that time, its price stood at some ¥730,000.
